It’s a short week for most people with the Easter long weekend, but we’ve still had an ongoing flu feud, pharmacy reports dropped and a new CEO announced for the PSA
Earlier this week, national president of the AMA Dr Michael Gannon suggested pharmacies lack the professionalism of GPs when it comes to flu vaccination. Criticising pharmacy over the fees it charges for the service, he said: “We just want the retail pharmacies to be every bit as professional as GPs are and indeed those employers who organise free vaccinations for their staff.”
Not surprisingly, his comments were met with outrage from pharmacists. “Michael Gannon just doesn’t know what he is talking about. As to the fee we charge, it is barely for the cost of the vaccine plus a couple of bucks for the service. Surely Michael Gannon should have some common sense that GP gets those vaccine at No Charge to give injection at No Charge,” said an AJP reader.
Meanwhile the Pharmacy Guild revealed figures that show half of Australian adults don’t plan to get vaccinated for the flu this year.
The TGA hit back at RMIT ABC Fact Check’s analysis that concluded Minister Hunt’s claim making codeine prescription-only would save 100 lives a year doesn’t stack up to evidence. “There has not been any recent data to suggest that 100 Australians are dying every year from over-the-counter codeine products,” the ABC Fact Check team found.
However the TGA was adamant that the number were not only correct, but were even an underestimate of the true figures.
We found out from a new IBISWorld report that My Chemist Retail Group holds nearly a full third of the entire community pharmacy market.
And finally, the PSA announced that it has appointed a new CEO in Graham Catt, who has a track record of working with national organisation including the RACGP and Australian Veterinary Association, where he has worked for the past decade.